X. Meng et al. / Journal of Organometallic Chemistry 693 (2008) 2597–2602
2601
1377(w), 1329(s), 1253(w), 1209(w), 1171(m), 1116(w), 1034(m),
914(m), 860(w), 817(w), 799(m), 742(m), 645(w) cmꢀ1
4. Experimental
.
4.1. General procedures
4.3. Synthesis of Cp*IrCl[o-C6 H4N(C6H3-Me-p)(CH@NC6 H3-Me-p)]
(1a)
All manipulations of air- and/or water-sensitive compounds
were carried out under nitrogen using standard Schlenk tech-
niques. Solvents were dried by refluxing with appropriate drying
agents and distilled under nitrogen prior to use. All chemicals
which were commercially available were used without further
A solution of n-BuLi (1.6 M, 0.28 mL, 0.45 mmol) in hexane was
added dropwise to
a stirred solution of ligand L1 (0.123 g,
0.41 mmol) in THF (10 mL) at ꢀ78 °C. The mixture was slowly
warmed to room temperature and stirred for 3 h. The solvent
was removed under vacuum, and toluene (10 mL) was added to
the solid residue. The resultant mixture containing the lithium salt
of L1 was slowly channeled to a suspension of (Cp*IrCl2)2 (0.16 g,
0.2 mmol) in toluene (10 mL) and continuously stirred overnight
at room temperature. A dark red suspension was allowed to stand
for 1 day, and LiCl was removed by filtration. The solution was con-
centrated to about 3 mL, and cooled to ꢀ30 °C to obtain dark red
solid. Small red crystals were obtained through recrystallization
from hexane (0.19 g, 70%). Anal. Calc. for C31H34ClIrN2 (662.25):
C, 56.22; H, 5.17; N, 4.23. Found: C, 56.65; H, 4.91; N, 3.87%. 1H
NMR (400 MHz, CDCl3, 293 K): d 8.84 (s, 1 H, CH@NAr), 7.55 (d,
H, Ph–H), 7.42–7.39 (m, 8H, Ph–H), 7.15 (t, 1H, Ph–H), 7.08 (d,
1H, Ph–H), 6.60 (d, 1H, Ph–H), 2.52 (d, 6H, Ph–CH3), 1.18 (s, 15H,
Cp-5CH3) ppm. IR (KBr): 3052(w), 3011(w), 2914(s), 2860(s),
1612(s), 1591(s), 1503(s), 1496(m), 1436(m), 1372(w), 1338(m),
purification. The starting material [Cp*IrCl(
l-Cl)]2 was prepared
according to literature methods [6]. 1H NMR spectra were recorded
with a Varian Unity-400 spectrometer. Elemental analyses were
performed on an Elementarvario EL III Analyzer. Cyclic voltamme-
try (CV) was carried out on CH Instruments electrochemical work-
station (model 600A) at a scanning rate of 50 mV/s. Complex 1a
was dissolved in CH2Cl2 using 0.1 M N(nBu)4PF6 as the supporting
electrolyte [10]. UV spectra were recorded at room temperature
with an Agilgent instrument 8543.
4.2. Synthesis of o-C6H4NH (C6H3-Me-p)(CH@NC6H3-Me-p) (L1)
Ligands L1–L5 were prepared in good yields according to the lit-
erature without major modification, (2). Herein the synthesis of L1
will be taken as an example. A mixture of ortho-fluorobenzalde-
hyde (5.0 mL, 47.1 mmol), p-toluidine (5.0 g, 47.1 mmol), and
MgSO4 (1.0 g) in n-hexane (30 mL) was stirred for 2 h. The mixture
was filtered, and the yellow solid ortho-C6H4F(CHNC6H4Me-p) was
obtained after the solvent was removed, Pure product was ob-
tained by recrystallization from hexane. A solution of n-BuLi
(19.0 mL, 30.4 mmol) in hexanes was added to a solution of 2,6-
dimethylaniline (5.0 mL, 30 mmol) in THF (20 mL) at ꢀ78 °C. The
reaction mixture was warmed to room temperature and stirred
overnight. The resulting solution of LiNHAr was transferred into
a solution of ortho-C6H4F(CHNC6H4Me-p) (6.39 g, 30 mmol) in
THF (20 mL) at 25 °C. After stirring for 1 h, the reaction was
quenched with 10 mL H2O, the mixture was extracted with n-hex-
ane, and the organic phase was evaporated to vacuo to give a yel-
low solid crude product. Pure product was obtained as yellow
crystals by recrystallization from methanol. (5.4 g, 56%). Anal. Calc.
for C21H20N2 (300.4): C, 83.96; H, 6.71; N, 9.33. Found: C, 83.76; H,
6.91; N, 9.27%. 1H NMR (CDCl3): d 11.15 (s, 1H, NH), 8.59 (s, 1H,
CH@NAr), 7.40 (d, 1H, Ph–H), 7.28–7.12 (m, 10H, Ph–H), 6.77 (t,
1H, Ph–H), 2.37 (s, 3H, CH3), 2.35 (s, 3H, CH3). IR (KBr): 3200(w),
3072(w), 3011(w), 2914(s), 2878(s), 1617(s), 1594(s), 1566(s),
1518(s), 1452(s), 1325(m), 1181(m), 1155(m), 827(m), 750(m),
1165(m), 1104(m), 1026(m), 803(m), 742(m), 496(w) cmꢀ1
.
4.4. Synthesis of Cp*Ir[o-C6H4N(C6H3-Me-p)(CH@NC6 H3-Me-p)]
SO3CF3 (1b)
A solution of AgSO3CF3 (0.12 M, 1.6 mL, 0.2 mmol) in CH3CN
was added dropwise to a stirred solution of 1a (0.133 g, 0.2 mmol)
in toluene (10 mL) at room temperature. The mixture was stirred
for another 2 h, when the color gradually turned from dark red to
red. The solution was filtered to remove AgCl, and the solvent
was evaporated under vacuum to yield 2a (85%). Anal. Calc. for
C
32H34F3IrN2O3S (775.9): C, 49.53; H, 4.42; N, 3.61; S, 4.13. Found:
C, 50.01; H, 4.04; N, 3.84; S, 3.87%. 1H NMR (400 MHz, CDCl3,
293 K): d 9.00 (s, 1H, CH@NAr), 7.67 (d, 1H, Ph–H), 7.47–7.16 (m,
9H, Ph–H), 7.00 (d, 1H, Ph–H), 6.71 (d, 1H, Ph–H), 2.58 (d, 3H,
Ph–CH3), 2.52 (d, 3H, Ph–CH3), 1.18 (s, 15H, Cp-5CH3) ppm. IR
(KBr): 3026(w), 2918(s), 1610(s), 1575(s), 1536(s), 1504(m),
1454(m), 1270(s), 1222(m), 1148(s), 1030(s), 869(m), 762(m)
cmꢀ1
.
4.5. Synthesis of Cp*Ir[o-C6H4N(C6H3-Me-p)(CH@NC6H3-i-Me2-2, 6)]Cl
(2b)
517(m) cmꢀ1
.
The ligands L2–L5 were synthesized by the similar procedure
with L1, and all the 1H NMR resonances of these ligands were in
good accordance with the literatures.
Complex 2b was obtained in a similar strategy to that used in
the isolation of 1a (0.10 g, 75%). Anal. Calc. for C32H36ClIrN2
(676.28): C, 56.83; H, 5.37; N, 4.14. Found: C, 56.65; H, 4.99; N,
3.81%. 1H NMR (400 MHz, CDCl3, 293 K): d 8.82 (s, 1H, CH@NAr),
7.69 (d, H, Ph–H), 7.55 (d, 1H, Ph–H), 7.47–6.70 (m, 9H, Ph–H),
2.59 (d, 3H, Ph–CH3), 2.20 (d, 6H, Ph-2CH3), 1.16 (s, 15H, Cp-
5CH3) ppm. IR (KBr): 3388(m), 3072(s), 3061(s), 2960(m),
2865(w), 1600(s) 1505(s), 1499(s), 1447(m), 1404(m), 1326(s),
o-C6H4NH (C6H3-Me-p)(CH@NC6H3-Me2-2,6) (L2): Anal. Calc. for
C
22H22N2 (314.4): C, 84.04; H, 7.05; N, 8.91. Found: C, 83.95; H,
6.95; N, 8.90%. 1H NMR (CDCl3): d 11.07 (s, 1H, NH), 8.32 (s, 1H,
CH@NAr), 7.32–7.08 (m, 9H, Ph–H), 6.95 (m, 1H, Ph–H), 6.79 (m,
1H, Ph–H), 2.34 (s, 3H, PhCH3), 2.19 (m, 6H, Ph–CH3). IR (KBr):
3208(w), 3067(w), 3020(w), 2946(m), 2915(m), 2859(s), 2859(w),
1620(s), 1584(s), 1572(s), 1518(s), 1456(s), 1374(m), 1328(s),
1216(w), 1175(m), 1159(m), 1117(w), 1089(m), 1042(w), 910(m),
1179(m), 906(m), 768(m) cmꢀ1
.
859(w), 831(m), 801(w), 770(m), 754(m), 616(m) cmꢀ1
.
4.6. Synthesis of Cp*Ir[o-C6 H4N(C6H3-Me-p)(CH@NC6 H3-i-Pr2-2,6)]Cl
(3b)
o-C6H4NH (C6H3-Me-p)(CH@NC6H3-i-Pr2-2,6) (L3): Anal. Calc. for
C
26H30N2 (370.5): C, 84.28; H, 8.16; N, 7.56. Found: C, 84.20; H,
8.31; N, 7.35%. 1H NMR (CDCl3): d 11.05 (s, 1H, NH), 8.30 (s, 1H,
CH@NAr), 7.33 (t, 2H, Ph–H), 7.27 (m, 1H, Ph–H), 7.19–7.13 (m,
7H, Ph–H), 6.80 (t, 1H, Ph–H), 3.05(m, 2H, CH(CH3)2), 2.34(s, 3H,
PhCH3), 1.19–1.17 (m, 12H, CH(CH3)). IR (KBr): 3200(w), 3060(w),
2919(m), 2867(s), 1619(s), 1596(s), 1571(s), 1527(s), 1461(s),
Complex 3b was obtained in a similar strategy to that used in
the isolation of 1a (0.10 g, 75%). Anal. Calc. for C35H42ClIrN2
(732.28): C, 59.04; H, 6.06; N, 3.82. Found: C, 58.64; H, 6.44; N,
3.62%. 1H NMR (400 MHz, CDCl3, 293 K) d8.82 (s, 1H, CH@NAr),
7.82 (d, H, Ph–H), 7.42–7.10 (m, 9H, Ph–H), 6.62 (d, 1H, Ph–H),